Concepedia
Statistics
Publications
20
Citations
2.1K
H-Index
17
Active since
1989
Affiliations
Pfizer (United States)(Current)
Newcastle University
University of California, Irvine
University of Minnesota
Donald J. Skalitzky is an author at Pfizer (United States) specializing in chemistry, organic chemistry, and natural sciences.
Publications per year
1989–2021
Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361
Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 485 citations · Full text
Medicine, Oncology, Pharmacology +15
Stereochemistry of alternating polyol chains: 13C NMR analysis of 1,3-diol acetonides
Scott D. Rychnovsky, Donald J. Skalitzky · Tetrahedron Letters · 1990 · 478 citations
Natural Sciences, Biochemistry, Chemistry +7
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial
Huw D. Thomas, Christopher Calabrese, Michael A. Batey et al. · Molecular Cancer Therapeutics · 2007 · 302 citations
Tricyclic Benzimidazoles as Potent Poly(ADP-ribose) Polymerase-1 Inhibitors
Donald J. Skalitzky, Joseph Marakovits, Karen A. Maegley et al. · Journal of Medicinal Chemistry · 2002 · 152 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Optically pure 1,3-diols from (2R,4R)- and (2S,4S)-1,2:4,5-diepoxypentane
Scott D. Rychnovsky, George Griesgraber, Sam Zeller et al. · The Journal of Organic Chemistry · 1991 · 107 citations
Natural Sciences, Chemistry, Analytical Chemistry +6
1–5 of 20